USA - NASDAQ:BRZE - US10576N1028 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to BRZE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | Needham | Reiterate | Buy -> Buy |
| 2025-10-01 | Wells Fargo | Initiate | Overweight |
| 2025-10-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-09-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-05 | UBS | Maintains | Buy -> Buy |
| 2025-09-05 | Needham | Reiterate | Buy -> Buy |
| 2025-09-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-09-05 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-08-18 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-24 | Mizuho | Initiate | Outperform |
| 2025-06-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-06 | Macquarie | Maintains | Neutral -> Neutral |
| 2025-06-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-06 | UBS | Maintains | Buy -> Buy |
| 2025-06-06 | Needham | Reiterate | Buy -> Buy |
| 2025-06-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-06 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-06-06 | Loop Capital | Maintains | Buy -> Buy |
| 2025-06-06 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-06-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-03 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-16 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-14 | DA Davidson | Maintains | Buy -> Buy |
26 analysts have analysed BRZE and the average price target is 45.73 USD. This implies a price increase of 59.56% is expected in the next year compared to the current price of 28.66.
The consensus rating for BRAZE INC-A (BRZE) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.